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The gonad as well as the reproductive tracts, kidney, and adrenal cortex are derived from the intermediate mesoderm. In addition, the
intermediate mesoderm forms the mesonephros. Although the mesonephros is the source of certain testicular cell types, its contribution to
gonad formation through expression of growth factors is largely unknown. Here, we examined the expression profiles of FGF9 in the
developing mesonephros of chick embryos at sexually indifferent stages, and found that the expression domain is adjacent to the gonadal
primordium. Moreover, FGFR3 (FGF receptor 3) showed a strong expression in the gonadal primordium. Next, we examined the functions
of FGF signal during gonadal development with misexpressed FGF9. Interestingly, misexpression of FGF9 led to gonadal expansion
through stimulation of cell proliferation. In contrast, treatment with a chemical inhibitor for FGFR decreased cell proliferation and resulted in
reduction of the gonadal size. Simultaneously, the treatment resulted in reduction of gonadal marker gene expression. Our study demonstrated
that FGF expressed in the developing mesonephros is involved in the development of the gonad at the sexually indifferent stages through
stimulation of gonadal cell proliferation and gonadal marker gene expression.
D 2005 Elsevier Inc. All rights reserved.
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Basically, the developmental process of the reproductive
tissues seems conserved among vertebrates. In fact, several
transcription factors such as WT-1, SOX9, DAX-1 (NR0),
Ad4BP/SF-1 (NR5A1) and DMRT-1 (doublesex- and mab-
3-related transcription factor) implicated in mammalian
gonadal development are conserved in other vertebrate
animal species (Capel, 2000; Morohashi, 1997). Moreover,
some of them are known to be involved in gonadal0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: moro@nibb.ac.jp (K. Morohashi).development even in non-vertebrate animals (Asahina et
al., 2000; Zarkower, 2001). Therefore, a similar set of
transcription factors and thereby similar mechanisms are
likely to be involved in gonadal differentiation.
Developmentally, the reproductive tissues are derived
from the intermediate mesoderm, which initially appears
between the paraxial and lateral plate mesoderms (Kaufman,
1992). As an early event occurring in the intermediate
mesoderm, the nephric duct (feature Wolffian duct) pro-
gresses rostrocaudally towards the cloaca. From the
rostrocaudal aspect, this structure is divided into three
distinct regions; the pronephros, mesonephros, and meta-
nephros. In the three nephric regions, the nephrogenous
mesenchyme medial to the nephric duct undergoes exten-
sive epithelial transformation to form nephric tubules, while280 (2005) 150–161
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(Saxen, 1987). In the female, the Mqllerian duct develops
later into the mesonephros along with the nephric duct.
In addition to these reproductive tracts, the urogenital
ridge, the primitive stage of the gonad, starts to develop at
the ventral surface of the mesonephros. Studies of the
contribution of the mesonephros in this early process of
gonadal development demonstrated that mesonephric cells
migrate into the primitive gonad and eventually differentiate
into peritubular myoid and vascular endothelial cells (Buehr
et al., 1993; Martineau et al., 1997). However, the tissue
contribution has not been studied yet with respect to the
source of growth factor signals.
Patterning of multicellular tissue is regulated by
extracellular signals derived from neighboring cells. The
roles of various members of TGFh/BMP, WNT, FGF and
Hedgehog families have been highlighted from many
aspects of developmental processes in a variety of animals
(Huelsken and Birchmeier, 2001; Ingham and McMahon,
2001; Massague and Chen, 2000; Ornitz and Itoh, 2001).
With respect to the urogenital development, the functions
of these growth factors have been elucidated by gene
disruption studies in mice. For example, Wnt4 is required
for tubulogenesis in the kidney (Stark et al., 1994) and
differentiation of the female gonad and reproductive tract
(Vainio et al., 1999). Fgf9 is required for male gonadal
differentiation (Clark et al., 2000; Colvin et al., 2001),
while Dhh expressed in Sertoli cells is implicated in
Leydig cell differentiation (Schmahl and Capel, 2003; Yao
et al., 2002). Thus, all these growth factors produced in the
developing gonad seem to be essential for gonadal
differentiation in mammals. Nevertheless, the contribution
of the growth factors expressed in the mesonephros is
largely unknown.
In the present study, we defined the expression of
FGF9/Fgf9 in the chick and mouse mesonephroi at
sexually indifferent stages. To elucidate the functions of
the growth factors in the process of gonadal differen-
tiation, we adapted misexpression and chemical inhibition
studies in chick embryos. Based on their effects on the
expressions of the marker genes and morphological
changes, the present study revealed that the FGF signal
plays a crucial role at the sexually indifferent stages of
gonadal development.Materials and methods
In situ hybridization and immunohistochemistry
Section and whole-mount in situ hybridization were
performed essentially as described previously (Wilkinson,
1992) with minor modifications (Kawabe et al., 1999;
Yoshioka et al., 1998). The chick and mouse cDNA probes
used in this study were as follows. Chick Ad4BP/SF-1,
AMH, and SOX9 were provided by Kudo and Sutou (1997),Eusebe et al. (1996), and Kamachi et al. (1999), respec-
tively. FGFR1 (FGF receptor 1), FGFR2 (FGF receptor 2),
and FGFR3 (FGF receptor 3) were provided by Dr. Nohno
(Noji et al., 1993). FGFR4 (Clone ID; ChEST205p12) was
supplied by MRC Geneservice (Cambridge, UK). Chick
cDNA for DMRT-1 was obtained as described previously
(Raymond et al., 1999). To isolate mouse Fgf9 cDNA probe
(NM 013518), total RNA prepared from 12.5 dpc (days
postcoitum) fetuses was amplified by reverse transcription-
polymerase chain reaction (RT-PCR) with primers, 5V-
TGAAGTTGGGAGCTATTTCGGTGTGC-3V, and 5V-
GTTCAGGTACTTTGTCAGGGTCCACT-3V. To isolate
chick FGF9 cDNA, RT-PCR was performed using total
chick embryonic RNA at stage 30. Degenerate primers were
designed to target the amino acid sequences, MAPLGEVG
(5V primer) and KVPELYKD (3V primer). RT-PCR with the
primers produced a 609-bp fragment encoding FGF9 cDNA
lacking carboxy terminal. To obtain cDNA encoding the
carboxy terminal region, 3V-rapid amplification of cDNA
end was performed according to the instructions provided
by the manufacturer (Stratagene, La Jolla, CA). The full-
length cDNA for the chick FGF9 was obtained from the
above two cDNA fragments. The nucleotide sequence of the
chick FGF9 cDNA was deposited in the GenBank database
(AB108842). Two-color whole-mount in situ hybridization
with digoxigenin-labeled probes (Roche Molecular Bio-
chemicals, Inc., NJ) was performed as described previously
(Dietrich et al., 1997), except that Fast Red and BCIP/NBT
(Roche Molecular Biochemicals) were used for the first and
second staining, respectively. After colorimetric reaction,
the embryos were fixed with 4% paraformaldehyde/phos-
phate-buffered saline (PBS), and embedded in 2% agarose
or paraffin followed by sectioning using a vibratome or
microtome, respectively. For immunohistochemical analysis
of chick VASA homologue (CVH), the tissues were fixed
with 4% paraformaldehyde/PBS and embedded in paraffin.
Paraffin sections were dewaxed and hydrated by passing
through a xylene-ethanol series. To inactivate endogenous
alkaline phosphatase (AP) activity, the sections were treated
at 658C for 60 min. After three 20-min wash in PBS
containing 3% bovine serum albumin, the sections were
incubated overnight at 48C with a rabbit anti-CVH
(1:10,000) (Tsunekawa et al., 2000). AP-conjugated anti-
rabbit IgG (Vector Laboratories, Burlingame, CA) was used
as the secondary antibody. Section in situ hybridization was
performed according to the method described previously
(Xu and Wilkinson, 1998).
Manipulation of chick embryos with recombinant
retroviruses
The chick FGF9 cDNA was cloned into an avian
retrovirus vector RCASBP(A) (Hughes et al., 1987) and
transfected into chick embryonic fibroblasts (Fekete and
Cepko, 1993). The fibroblasts were trypsinized and packed
into a block by centrifugation to use for implantation
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the Hamburger and Hamilton’s staging table (Hamburger
and Hamilton, 1951). With embryos at stages 12–13, the
FGF9-expressing cells were implanted into the nephroge-
nous mesenchyme at the presumptive level of 23–24
somites since part of the nephrogenous mesenchyme at this
level forms the future gonads (Rodemer et al., 1986). The
embryos at appropriate stages were fixed with 4% paraf-
ormaldehyde in PBS, and thereafter processed for whole-
mount in situ hybridization, section in situ hybridization or
immunohistochemistry.
Implantation of FGF9 and SU5402-soaked beads
AG1-X2 ion exchange resin beads (150–200 Am
diameter; Bio-Rad, Richmond, CA) were prepared (Eichele
et al., 1984). They were soaked for 1 h in 10 mM solution of
SU5402 (Calbiochem, La Jolla, CA; Mohammadi et al.,
1997) in dimethyl sulfoxide (DMSO) or otherwise in
DMSO alone as control. The beads were washed with
PBS and thereafter implanted into the coelomic epithelium
corresponding to the presumptive FGF9 expressing-region
at stage 18–19. The implanted embryos were incubated for
36 h at 388C. Heparin acrylic beads (Sigma, St Louis, MO)
were soaked in 0.5 mg/ml of human recombinant FGF9
(Pepro Tech EC, London, UK) or bovine serum albumin
(BSA) for 1 h at 48C. The beads were implanted into the
coelomic epithelium corresponding to the presumptive
gonadal region at stage 18–19. The implanted embryos
were incubated for 24 h at 388C.
BrdU labeling and detection
To examine cell proliferation, 1 Al bromodeoxyuridine
(BrdU) solution (10 Ag/Al in H2O with 0.01% Fast Green)
was injected into embryos implanted with the FGF9-
expressing cells, FGF9-soaked, or SU5402-soaked beads
through the vitelline vein. After 60-min incubation at
388C, the embryos were fixed with 4% paraformaldehyde/
PBS and embedded in paraffin. The paraffin sections were
dewaxed, hydrated and then treated with 10 mM
trisodium citrate (pH 6.0) for 20 min to activate nuclear
antigens (Nomura et al., 1998). After two 5-min washes
with PBS, the sections were incubated with a mouse anti-
BrdU monoclonal antibody (Roche, 1:100) for 1 h at
378C. The sections were washed five times with PBS,
each for 5 min, and further incubated with Cy3-labeled
anti-mouse antibody (IgG, Jackson Immunoresearch Lab-
oratories, West Grove, PA, 1:500) for 1 h at 378C. After
washing with PBS again, the sections were examined for
immunofluorescence.
Sexing of tissue samples
The sex of the chick embryo was determined by the
presence or absence of the W chromosome. PCRamplification of W-specific XhoI repeat was performed
with a genomic DNA as a template (Kent et al., 1996).
The sex of mouse embryo was determined by PCR
amplification of the Sry (Gubbay et al., 1992) and Zfy
(Hogan et al., 1994).Results
Expression of Ad4BP/SF-1 and DMRT-1 in the developing
gonadal and adrenal primordia
Previous studies reported that several genes correspond-
ing to those involved in mammalian gonadal development
are also expressed in the embryonic chick gonads (Smith
and Sinclair, 2001). We determined in detail the expres-
sion profiles of Ad4BP/SF-1 (gonadal and adrenal marker)
and DMRT-1 (gonadal marker) at sexually indifferent
stages of the chick embryos. Gonadal sex differentiation is
known to start at around stages 28–30. Whole-mount in
situ hybridization revealed that the expression of Ad4BP/
SF-1 in the developing mesonephric mesenchyme starts by
stage 19 and continues in the following stages (Figs. 1A,
D, J). The expression of DMRT-1, which was undetectable
at stage 19 (data not shown), appeared by stage 21 (Fig.
1G). At the following stage 24, the expression was
detected in two separate domains at the lateral sides of
each mesonephros (arrowheads in Fig. 1M). Although the
expression patterns of DMRT-1 in the two sexes were
quite similar, the expression in the male was higher than
in the female (data not shown), presumably because of its
localization on the Z sex chromosome (Raymond et al.,
1999).
Cross-sections revealed that Ad4BP/SF-1 was expressed
as a single cell group at the medial side of the
mesonephric mesenchyme at stages 19 and 21 (Figs. 1B,
C, E, F). By stage 24, the cell group divided into two
main subgroups, one was located proximal to the coelomic
epithelia (ventral domain) and the other proximal to the
dorsal aorta (dorsal domain) (Fig. 1L). Based on our
previous observation in rat fetuses (Hatano et al., 1994,
1996), the ventral and dorsal domains seem to correspond
to the gonadal (gp in Fig. 1) and adrenal (adp in Fig. 1)
primordia, respectively, and the single cell group observed
at stage 19 is probably the adreno-gonadal primordium
(agp in Fig. 1). The expression of DMRT-1 was localized
in the ventral aspect of the mesonephric mesenchyme,
which positionally corresponds to the gonadal primordium
(Figs. 1I, O). In addition, the expression was clearly
observed at the lateral aspect to the mesonephros (Figs.
1N, O). Considering that the expression of DMRT-1 at
stage 21 overlaps with that of Ad4BP/SF-1 at the ventral
but not the dorsal part, the cells expressing Ad4BP/SF-1
seem to have the potential to develop into the gonad or
adrenal cortex before they separate into the two subgroups
(Fig. 1F).
Fig. 1. Expression of Ad4BP/SF-1 and DMRT-1 in the developing nephrogenous mesenchyme. Expression of Ad4BP/SF-1 and DMRT-1 in the developing
nephrogenous mesenchyme of the chick embryos was examined. Whole mount in situ hybridization was performed with the probes for Ad4BP/SF-1 (A–F, J–L)
and DMRT-1 (G–I, M–O). Ventral views of the examined embryos are shown (A, D, G, J, M). These samples were cross-sectioned (30 Am) at the indicated
levels (levels B and C in A, levels E and F in D, levels H and I in G, levels K and L in J, and levels N and O in M). Chick embryos were used at stage 19 (A, B,
C), stage 21 (D–I), and stage 24 (J–O) as indicated in the panels. Arrowheads in M indicate two separate DMRT-1-expressing domains. The expressions of
male embryos are shown. agp; adreno-gonadal primordium, gp; gonadal primordium, adp; adrenal primordium. Scale bars in A, D, G, J, and M = 200 Am,
while in B, C, E, F, H, I, K, L, N, and O = 100 Am.
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of chick and mouse mesonephroi
The intermediate mesoderm is initially defined as a
discrete cell aggregate between the paraxial and lateral plate
mesoderms at stage 9 of chick embryos, and subsequently
develops into the nephric duct and nephrogenous mesen-
chyme. The nephrogenous mesenchyme forms condensed
cell aggregates, where mesenchymal to epithelial trans-
formation occurs extensively, followed by development of
the mesonephric tubules (Friebova-Zemanova, 1981). The
expression of FGF9 started at the anterior side of the
mesonephros as early as stage 18 and thereafter expanded
posteriorly (data not shown). At stage 21 when the
mesonephric tubules had developed extensively, FGF9
was expressed in the developing mesonephros of male
chick embryos (Fig. 2A). Likewise, the expression was
observed in female embryos (data not shown).
It is well known that the development of Bowman’s
capsule and thus its antecedent structure, a comma-shaped
body, is essential to establish the excretory apparatus in the
kidney, and therefore these structures are characteristic
primarily of the metanephros in mammals. However, in
chick embryos, the particular structures are well organized
even in the mesonephros (Friebova-Zemanova, 1981). The
comma-shaped bodies start to appear at stage 18 at the
mesenchyme adjacent to the lateral tip of the mesonephrictubules, and subsequently develop into Bowman’s capsule
as illustrated in Fig. 2B. At stage 21, the expression of
FGF9 was clearly observed in this particular structure, the
comma-shaped body (Fig. 2C). At the later stage 30, when
sexually indifferent gonads start to develop sex-depend-
ently, the expression of FGF9 was decreased in the
mesonephros, whereas the expression appeared in the
epithelial cells of the gonads of both sexes. The FGF9
expression in the male was higher than that in the female
(Figs. 2D, E, F, G). Interestingly, the expression in the left
gonad of the female was stronger than that in the right
gonad (Fig. 2G). It is well known that the right ovary
degenerates gradually soon after the sex of indifferent
gonads is determined into the ovary. The downregulation of
FGF9 expression in the female right gonad may lead to the
following ovarian degeneration.
Although it was shown that Fgf9 is expressed in the
sexually differentiating mouse gonads (Colvin et al., 2001;
Schmahl et al., 2004), its expression at the developing
mesonephros has not yet been defined. Sexually indifferent
mouse fetuses at 9.5 and 10.5 dpc (days postcoitum) were
subjected to whole mount in situ hybridization. Similar to
the chick embryos, Fgf9 was expressed in the developing
mouse mesonephric mesenchyme at 9.5 dpc (Fig. 2H).
Cross-sections clearly showed that certain part of the
mesonephric mesenchyme adjacent to the mesonephric duct
was the expression domain of Fgf9 (Fig. 2I). Any clear
Fig. 2. Expression of chick and mouse FGF9/Fgf9 in developing urogenital regions. The expression of FGF9 was examined in the developing urogenital
region of the sexually indifferent stage (stage 21) of male chick embryos (A). The developing nephrogenous mesenchyme is schematically represented (B). cb;
comma-shaped body, nd; nephric duct, nt; nephric tubule, gp; gonadal primordium, adp; adrenal primordium. A cross-section (30 Am) (C) was prepared at the
level indicated in A. The expression of FGF9 was examined in the mesonephros and sexually differentiating gonads of male (D) and female (F) at stage 30.
Cross-sections (30 Am) (E and G) were prepared at the levels indicated in D and F. R; right gonad, L; left gonad. The Fgf9 expression in the developing mouse
urogenital region was examined with sexually indifferent stages, 9.5 (H) and 10.5 dpc (J), of male fetuses. Cross-sections (30 Am) (I and K) were prepared at
the levels indicated in H and J. The sex of each chick and mouse embryo is indicated. Scale bars in A, D, and F = 300 Am, in C, H, and J, = 100 Am, and in E
and G = 50 Am, in I and K = 20 Am.
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between the two sexes (data not shown). The mesonephric
expression decreased at 10.5 dpc (Figs. 2J, K) and
disappeared eventually (data not shown).
Spatially correlated expression of gonadal marker genes
with FGF9 and FGFRs in the developing mesonephros
Based on the expression patterns of FGF9, Ad4BP/SF-1,
and DMRT-1 described above, the expression of these genes
seemed spatially related. To define the relationship, the
expression of FGF9 was compared directly with those of
Ad4BP/SF-1 and DMRT-1 by two-color whole mount in situ
hybridization. At stage 21, FGF9 was expressed along with
Ad4BP/SF-1 and DMRT-1 in the mesonephric mesenchyme
(Figs. 3A, C). Cross-sections revealed that the expression
domain of FGF9 was adjacent to the ventral but not dorsal
half of the expression domain of Ad4BP/SF-1 (Fig. 3B).
Likewise, the expression domain of FGF9 was adjacent to
that of DMRT-1 (Fig. 3D), indicating that FGF9 is
expressed adjacent to or somewhat overlapped with the
gonadal primordium.
The expression patterns of FGF receptors (FGFR1,
FGFR2, FGFR3, and FGFR4) were examined in chick
embryos. It has been established that these receptors exhibit
different expression patterns in various developing tissues.Likewise, their expressions in the mesonephric region were
specific to each receptor. At stage 19, FGFR1 was
expressed in the whole part of the mesonephric region
(Figs. 3E, I). A strong expression of FGFR2 was observed
in the nephric duct while a modest expression was observed
in the mesonephros near the mesentery (Figs. 3F, J).
Showing an expression pattern nearly complementary to
FGFR2, FGFR3 was expressed in the mesonephros except
the nephric duct (Figs. 3G, K). No clear expression of
FGFR4 was detected in the mesonephric region (Figs. 3H,
L). At the following stage 21, the expression of FGFR1 was
retained in the mesonephric mesenchyme proximal to the
nephric duct and in the ventral epithelial cell layer covering
the mesonephros (Fig. 3M). The expression of FGFR2 was
basically identical to that at stage 19 (Fig. 3N). Interestingly,
the expression of FGFR3 appeared to be confined to the
gonadal primordium at this stage (Fig. 3O). Finally, FGFR4
was weakly expressed in the nephric duct but not in other
parts of the mesonephric region (Fig. 3P).
Expansion of chick gonad by misexpressed FGF9
The expression profiles described above strongly
suggested the involvement of FGF9 in the sexually
indifferent stages of gonadal development. To examine
this possibility, FGF9 was misexpressed in the developing
Fig. 3. Spatial correlation of the expression domain of FGF9 with those of Ad4BP/SF-1, DMRT-1, and FGF receptors in the developing mesonephros. With
chick embryos at stage 21, two-color whole mount in situ hybridization was performed with probes for FGF9 (blue signal) and Ad4BP/SF-1 (red signal) (A) or
FGF9 (blue signal) and DMRT-1 (red signal) (C). Cross-sections (B, D) (30 Am) were prepared as indicated in A and C. Whole-mount in situ hybridization
probed with FGF receptors, FGFR1 (E, I, M), FGFR2 (F, J, N), FGFR3 (G, K, O), and FGFR4 (H, L, P) was performed in male chick embryos at stages 19
(E–L) and 21 (M–P). Cross-sections (30 Am) prepared from the examined embryos are shown. Insets in E, F, G, and H correspond to I, J, K, and L,
respectively. Arrowheads in B, D, and M–P indicate the gonadal primordium, while arrows with cb indicate comma-shaped body. nd; nephric duct. Scale bars
in A and C = 350 Am, and in B, D, and E–P = 100 Am.
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retrovirus vector. The viruses expressing FGF9 were
spread throughout the operated right mesonephros (data
not shown). The chick embryos implanted with the FGF9-
expressing cells were incubated until the gonads underwent
sex differentiation (stage 30–31). Interestingly, the whole
view of the gonad highlighted by the expression of
Ad4BP/SF-1 showed that the misexpression of FGF9
affected gonadal development (Fig. 4A). In fact, cross-
sections clearly revealed irregular expansion of the gonads
(Fig. 4B). Likewise, the expression of DMRT-1 was also
detected in the particular cells, indicating that the cells
acquired specificity as gonadal cells (Figs. 4C, D).
Unexpectedly, however, all embryos were dead by day
five after operation possibly because of the toxic effects of
the misexpressed FGF9. Thus, it was unclear whether the
expanded gonadal region would potentially develop into a
functional tissue. In addition to examining the effects of
the misexpressed FGF9 on the gonad, we also checked its
effects on the mesonephros. However, we could not detect
any obvious expansion of the mesonephroi in the embryosimplanted with the FGF9-expressing cells. Therefore, it is
unlikely that FGF9 is implicated in the mesonephric
development.
A null mutation of Fgf9 in the mouse was reported to
result in a decrease in the marker gene expression for Sertoli
and Leydig cells of the fetal testis, and thus, it was
concluded that the XY gonads of the gene disrupted mice
were somewhat sexually reversed to female (Colvin et al.,
2001). To investigate whether misexpression of FGF9
affects the chick gonadal sex, we examined the expressions
of SOX9 and Aromatase genes, which are representative
marker genes for the testis and ovary, respectively. Although
the expression of SOX9 was detected in the expanded region
of the male gonad (Figs. 4E, F), the expression was neither
detected in the expanded female gonad nor in the authentic
female gonad (Figs. 4G, H). Conversely, the expression of
Aromatase was detected in the expanded region of the
female gonad (Figs. 4I, J), but not in that of the male (Figs.
4K, L). Implantation of the AP-expressing cells did not
affect the expressions of these marker genes in both sexes
(Figs. 4M–Q, T).
Fig. 4. Gonadal expansion by misexpression of FGF9. FGF9-expressing cells (A–L, R, S) or AP-expressing cells (M–Q, T, U) were implanted into the
nephrogenous mesenchyme at stage 12–13. After incubation for 5 days (stage 30), the embryos were subjected to in situ hybridization probed with Ad4BP/SF-1
(A, B), DMRT-1 (C, D), SOX9 (E–H), and Aromatase (I–L). The FGF9-expressing cells were implanted into 421 embryos, and 186 embryos that developed up
to stage 30 were studied; analysis of Ad4BP/SF-1 expression was conducted in 18 male and 19 female embryos, analysis of SOX9 expression was conducted in
16 male and 18 female embryos, analysis of DMRT-1 expression was conducted in 19 male and 20 female embryos, and analysis of Aromatase expression was
conducted in 15 male and 15 female embryos. The expanded gonads indicated by arrowheads were observed in 78% of the embryos examined. The AP-
expressing cells were implanted into 247 embryos and 113 embryos that developed up to stage 30 were studied; analysis of Ad4BP/SF-1 expression was
conducted in 13 male and 11 female embryos, analysis of SOX9 expression was conducted in 10 male and 10 female embryos, analysis of DMRT-1 expression
was conducted in 13 male and 14 female embryos, and analysis of Aromatase expression was conducted in 11 male and 10 female embryos. The tissues were
cross-sectioned (B, D, F, H, J, L) at the levels indicated in A, C, E, G, I, and K. Likewise, the embryos implanted with the AP-expressing cells were used for in
situ hybridization probed with Ad4BP/SF-1 (M, N), DMRT-1 (O), SOX9 (P), and Aromatase (Q). A–F and K–P represent studies in male embryos, while G– J
and Q were conducted in female embryos. Arrows in A and M indicate developing adrenal cortex. For analyses of AMH and CVH expressions, the embryos
implanted with the FGF9 (R, S) or AP-expressing cells (T, U) were incubated for 5.5 days (stage 31). The FGF9-expressing cells were implanted into 75
embryos and 31 (16 male and 15 female) embryos that developed up to stage 31 were used in this study (R, S). The AP-expressing cells were implanted into 51
embryos and 22 (12 male and 10 female) embryos that developed up to stage 31 were used for this study (T, U). Tissue sections prepared from the male
embryos were subjected to in situ hybridization for AMH (R, T) and immunohistochemical analysis for CVH (S, U). The asterisk in S indicates the location
corresponding to the expanded gonad in R. Arrows show PGCs distributed in the expanded gonad (S). Scale bars in A, C, E, G, I, K, and M = 300 Am, and
those in B, D, F, H, J, L, N, O, P, Q and R–U = 50 Am.
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(PGCs) migrate toward and settle even at the gonad of
the expanded region. In order to visualize PGCs,
immunohistochemical studies were performed with an
antibody to a chick vasa homologue (CVH) (Tsunekawa
et al., 2000), which is a marker for PGCs (Olsen et al.,
1997; Yoon et al., 1997). To localize the expanded
region of the gonad, the section was subjected to in situ
hybridization probed with AMH (Fig. 4R), and the
adjacent section was used for CVH staining. As shown
in Fig. 4S, PGCs mostly migrated into the gonad while
a number of PGCs remained at or around the expanded
gonadal region. Expectedly, all PGCs were localized in
the gonad when treated with the AP-expressing cells
(Figs. 4T, U).Effects of FGF signal on gonadal cell proliferation
To elucidate the mechanisms of gonadal expansion by
the misexpressed FGF9, we asked whether FGF9 stim-
ulates gonadal cell proliferation. In order to confine the
effects of FGF9 within the gonadal region, FGF9-soaked
(Figs. 5A–F) and BSA-soaked beads (Figs. 5G–L) were
implanted into the developing right mesonephric mesen-
chyme at stage 18–19. Since the expression profiles of
FGF9 and FGFRs did not show any difference between
the two sexes and a similar gonadal expansion was
observed in both sexes, male embryos were used in this
study. After incubation for 24 h, the primitive but
structurally distinguishable gonad was developed. BrdU
was injected into the operated chick embryos and BrdU-
Fig. 5. Effects of FGF9 on gonadal cell proliferation. FGF9-soaked beads
were implanted into the coelomic epithelium at stage 18–19 of male
embryos (A–F). As a control, BSA-soaked beads were used (G–L).
Asterisks indicate the location of beads (A, B, G, and H). BrdU was
injected into the operated embryos 1 h prior to the end of 24-h incubation
after operation (stage 24). Six embryos were used for each beads-
implantation study and three of them were subjected to immunohisto-
chemical analysis with anti-BrdU antibody (B, D, H, J), while the nuclei
were stained with DAPI (A, C, G, I). Insets in C, D, I, and J are enlarged
in E, F, K, and L, respectively. The gonadal region was determined by in
situ hybridization probed with Ad4BP/SF-1 using consecutive sections
(data not shown). Five tissue sections were selected randomly, and
numbers of the immunoreactive and total cells in the areas encircled by
dotted lines in E, F, K, and L corresponding to the gonads were counted
and are plotted in M. Data shown in M are mean F SD numbers of
immunoreactive cells relative to the total number of cells when the
relative cell number in the right gonad of the embryo implanted with the
BSA-soaked bead was considered 1 unit. BSA R and BSA L; the right
and left gonad of the embryo implanted with the BSA-soaked bead,
respectively, FGF9 R and FGF9 L; the right and left gonad of the embryo
implanted with the FGF9-soaked bead, respectively. The immunoreactive
cell numbers per total cell numbers are as follow. Experiment 1; BSA R =
24/114, BSA L = 32/186, FGF9 R = 30/161, and FGF9 L = 20/147,
Experiment 2; BSA R = 14/95, BSA L = 19/114, FGF9 R = 17/62, and
FGF9 L = 11/101, Experiment 3; BSA R = 14/62, BSA L = 26/134,
FGF9 R = 20/71, and FGF9 L = 13/95. Scale bars in A–D and G–J = 100
Am, while in E, F, K, and L = 25 Am.
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nohistochemically. As indicated in Fig. 5M, the relative
number of the proliferating cells in the operated right
gonad (Fig. 5E) was approximately 1.3-fold higher than
that in the unoperated left gonad (Fig. 5F). No such
enhanced cell proliferation was noted when the BSA-
soaked beads were implanted (Figs. 5K, L).Effects of FGF signal inhibitor on gonadal marker gene
expression and gonadal cell proliferation
To characterize the effects of FGF signal on gonadal
marker gene expression, beads soaked with SU5402, an
inhibitor for FGF receptor, were implanted. After the
embryos were incubated for 36 h, they were cross-sectioned
at the level of the implanted bead (Figs. 6A, C) and both at
anterior (Figs. 6B, D) and posterior (data not shown) levels
relative to that of the implanted bead. In situ hybridization
with these sections revealed marked reduction of the
gonadal expression of Ad4BP/SF-1 when compared with
sections of the fetuses implanted with control solvent
(DMSO)-soaked bead (Figs. 6I, J). The effect of SU5402
was detected even in the unoperated left gonad although the
effect seemed weaker than that in the right gonad. Similar to
the effects on the expression of Ad4BP/SF-1, the expression
of DMRT-1 decreased (Figs. 6C, D). The beads soaked with
control solvent (DMSO) had no effect on the expressions of
DMRT-1 (Figs. 6K, L). Interestingly, the expression of
Ad4BP/SF-1 at the adrenal primordium seemed unaffected
(indicated by arrows with ad in Figs. 6A, B).
In addition to the effects on the marker gene expression,
the gonads of the embryos implanted with the SU5402-
soaked beads were smaller than those with the DMSO-
soaked beads. Therefore, we examined whether SU5402
inhibits gonadal cell proliferation. The bead-implanted
embryos were labeled with BrdU and subjected to
immunohistochemical analysis (Figs. 6E–H, M–P). Implan-
tation of the SU5402-soaked beads resulted in 37%
reduction in the number of proliferating cells at the
operated right gonad compared with the embryos implanted
with the DMSO-soaked beads (Figs. 6G, O, Q). Approx-
imately 10% reduction of cell proliferation was observed
even at the left gonad of the SU5402 bead implanted
embryo (Figs. 6H, P, Q). Since the chemical reagent can
potentially inhibit signals from all types of FGFs, the
inhibition study does not necessarily lead to the conclusion
that FGF9 is essential for gonadal cell proliferation. In fact,
it was reported that FGF2 is expressed in the developing
mesonephric mesenchyme of the chick embryo (Savage
and Fallon, 1995), and the receptor specificity of FGF2
overlaps with that of FGF9 (Ornitz et al., 1996). Therefore,
although the exact FGF molecule responsible for gonadal
cell proliferation remains elusive, it is reasonable to
conclude that the FGF signal is essential for early gonadal
cell proliferation.Discussion
A novel expression domain of FGF9/Fgf9 during gonadal
development
In mammals, Bowman’s capsule appears in the
metanephric kidney and functions as a filter for renal
Fig. 6. Effects of FGF signal inhibitor, SU5402, on gonadal marker gene expression and gonadal cell proliferation. SU5402-soaked beads were implanted into
the coelomic epithelium at stage 18–19 of male embryos (A–H). As a negative control, DMSO-soaked beads were used (I–P). BrdU was injected into the
operated embryos 1 h prior to the end of 36-h incubation after operation (stage 25). After fixation, they were subjected to in situ hybridization probed with
Ad4BP/SF-1 (A, B, I, J) and DMRT-1(C, D, K, L) or used for immunohistochemical analysis for BrdU incorporation (F, N). The sections used for detection of
BrdU were stained with DAPI (E, M). The insets in E, F, M, and N are enlarged and indicated as merged images (G, H, O, P). Five tissue sections were selected
randomly, and the numbers of the immunoreactive cells and total cells encircled the dotted lines corresponding to the gonads were counted. The gonadal region
was determined by in situ hybridization probed with Ad4BP/SF-1 using consecutive section (O, P) or predicted structurally (G, H). The immunoreactive cell
numbers relative to the total cell numbers are presented when the relative cell number in the right gonad of the embryo implanted with the DMSO-soaked bead
was considered 1 unit (Q). Six embryos were used for each beads-implantation study. Three of the SU5402-beads and DMSO-beads implanted embryos were
subjected to immunohistochemical analysis using anti-BrdU antibody. DMSOR and DMSO L; the right and left gonad of the embryo implanted with the DMSO-
soaked bead, respectively, SU5402 R and SU5402 L; the right and left gonad of the embryo implanted with the SU5402-soaked bead, respectively. Data shown in
Q are mean F SD of three embryos. The immunoreactive cell numbers per total cell numbers are as follow. Experiment 1; DMSO R = 65/260, DMSO L = 64/
280, SU5402 R = 24/113, and SU5402 L = 60/300, Experiment 2; DMSO R = 112/490, DMSO L = 139/600, SU5402 24/203, and SU5402 L = 52/259,
Experiment 3; DMSO R = 79/334, DMSO L = 90/390, SU5402 R = 21/138, and SU5402 L = 51/267. Arrowheads marked R and L indicate the right and left
gonad, respectively, while arrows marked ad indicate the adrenal primordia. Asterisks indicate the implanted beads. Scale bars in A–F and I–N = 100 Am, while
in G, H, O, and P = 25 Am.
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in the mesonephros in addition to the metanephros
(Friebova-Zemanova, 1981), and functions in a manner
similar to that in the metanephric kidney (Zemanova et
al., 2002). Interestingly, we found that FGF9 was
expressed in the primitive stage of the developing
Bowman’s capsule (corresponding to the comma-shaped
body), which is localized adjacent to the tip of the
growing mesonephric tubule. Moreover, the expression
profile of FGF9 was comparable with those of gonadal
markers, DMRT-1 and Ad4BP/SF-1 . Based on the
expression domains of the gonadal marker genes, the
expression domain of FGF9 was found to be adjacent to
the gonadal primordium.Similar to the chick FGF9, the expression of Fgf9 was
confirmed in the mesonephros of mouse fetuses. Although it
was difficult to identify structurally the developing comma-
shaped body in the mouse mesonephros, Fgf9 seems to be
expressed adjacent to the gonadal primordium and function
as the signal for the sexually indifferent stage of gonadal
development. In addition to this mesonephric expression,
Fgf9 has been reported to be expressed in sexually
differentiating gonads of the mouse fetuses (Colvin et al.,
2001). Similarly, the present study revealed that FGF9 is
expressed in epithelial cells of the chick embryonic gonads.
As described below, FGF9/Fgf9 expressed in these two
distinct domains probably have distinct functions during
gonadal development.
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urogenital development
The FGF signal is mediated by four receptor molecules,
FGFR1 to FGFR4. We found in the present study that
FGFRs are expressed in the developing mesonephric
mesenchyme in a manner specific for each receptor, some
of which are consistent with the observation by Walshe and
Mason (2000). Noticeably, FGFR3 is clearly expressed in
the gonadal primordium. Considering that FGF9 potentially
binds to FGFR3 with high specificity (Ornitz et al., 1996), it
is reasonable to assume that FGF9 expressed in the
developing comma-shaped body stimulates the neighboring
gonadal primordium.
Based on these observations, we investigated whether
FGF9 acts as a signal for gonadal differentiation by
implantation of FGF9-expressing cells and FGF9-soaked
beads. Surprisingly, misexpression of FGF9 resulted in
gonadal expansion as was seen in the limb bud (Niswander,
2003) and genital tubercle (Haraguchi et al., 2000) when
they were stimulated by particular types of FGF molecules.
Because of increased BrdU incorporation at the gonadal
region, this effect of gonadal expansion by FGF9 mis-
expression is potentially caused by increased cell prolifer-
ation. Consistent with this observation, studies using a
chemical inhibitor of FGFR clearly indicated that inhibition
of FGF signal resulted in decreased cell proliferation and
eventually reduction of the gonadal size. Our results are in
agreement with those of recent in vitro tissue (Schmahl et
al., 2004) and cell (Willerton et al., 2004) culture studies of
mouse fetal gonads, which showed stimulation of gonadal
cell proliferation by human recombinant FGF9. Taken
together, this function of FGF9 in the developing gonad
seems to be common action in the two animals.
When discussing the FGF9 function, the phenotype of
the Fgf9 gene disrupted mouse (Colvin et al., 2001) should
be considered. Although the mouse showed male-to-female
sex reversal, the gonad was obviously present. Since the
mesonephric Fgf9 should disappear from the gene disrupted
mouse, the presence of the gonad indicated that mesoneph-
ric Fgf9 is not essential for gonad development. However,
our present study in chick indicates that FGF9 alone can
induce gonad formation. A proper interpretation of these
two results is that another unknown FGF is expressed in the
mesonephros and compensates for Fgf9 deficiency. Con-
sidering that SU5402 markedly decreased the gonadal size
and the expression levels of the gonad marker genes, it can
be assumed that both FGF9 and the presumptive FGF
potentially stimulate gonadal cell proliferation. In fact, the
expression of FGF2 was described in the chick mesonephric
mesenchyme (Savage and Fallon, 1995). Moreover, since
FGF2 potentially binds to FGFR3 as FGF9 does (Ornitz et
al., 1996), this FGF is a potential candidate to compensate
the FGF9 function during the early gonad development. We
also noted the expression of FGFR2 in the developing
gonadal primordium although the signal was weaker thanthat of FGFR3. Similar to the possible contribution of
multiple FGFs, it is possible to assume that multiple FGFRs
are involved in the process of the sexually indifferent
gonadal development.
With respect to the molecular mechanism underlying
gonadal expansion, we should consider the possibility that
the expanded gonadal cells originated from the cells once
committed to mesonephric cell lineage. In the misexpression
study, however, it was confirmed that the ectopic FGF9
expression spread throughout the mesonephric region.
Nevertheless, gonadal expansion occurred at restricted areas
neighboring the authentic gonad, suggesting that not all
mesonephric cells necessarily differentiate into the gonadal
cells upon FGF9 stimulation. Concerning the distinct effects
of FGF9 on the gonad and mesonephric cells, it is
noteworthy that FGF18 has dual function to stimulate the
differentiation and proliferation of osteogenic cells and
simultaneously suppress those of chondrogenic cells, and
importantly these distinct functions are mediated by distinct
types of FGFRs (Liu et al., 2002; Ohbayashi et al., 2002).
The distinct response to FGF9 stimulation might be due to
different types of FGFR expressed in the gonadal primor-
dium and other mesonephric mesenchyme.
Function of FGF signal at the stage of gonadal sex
differentiation
It was reported that Fgf9 gene disruption results in
male-to-female sex reversal in mice, displaying marked
reduction of both Sertoli (SOX9 and AMH) and Leydig
(cholesterol side chain cleavage P450) cell markers
accompanied by structural alterations in the testis (Colvin
et al., 2001). In contrast, the present FGF9 misexpression
study failed to activate SOX9 expression in the chick
ovary. In agreement with this finding, a recent tissue
culture study of mouse fetal gonad revealed that human
recombinant FGF9 failed to activate the expression of
Sertoli marker genes (Sox9, Mis, and Dhh) (Schmahl et al.,
2004). Taken together, the results indicated that FGF9 is
essential but not capable of activation of Sertoli cell
differentiation. Another yet unknown male-specific factor
seems to cooperate with FGF9 to ensure the process of
testicular differentiation. Consistent with this assumption,
Schmahl et al. (2004) recently described that the sexually
dimorphic property of extracellular matrix is crucial for
testicular differentiation. Indeed, they reported that the
extracellular matrix exhibits a high affinity to FGF9 and is
distributed abundantly in the male gonad more than the
female. Considering that the male-specific presence of the
extracellular matrix contributes to testicular formation, it is
conceivable that the misexpressed FGF9 failed to reverse
the gonadal sex from a female to male.
In the present study, we found and characterized a novel
expression domain for FGF9 in the developing mesoneph-
ros. In addition to its function related to testicular differ-
entiation, FGF9 expressed in this domain is involved in the
H. Yoshioka et al. / Developmental Biology 280 (2005) 150–161160early step of gonadal differentiation in both sexes through
the stimulation of gonadal cell proliferation and marker gene
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